NCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
Clinical Trials
1 trialsLymphoma, Large B-Cell, Diffuse × omeprazole, sodium bicarbonate drug combination × 1 year × Clear all